{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:44:22Z","timestamp":1792813462153,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.neulet.2019.134437","type":"journal-article","created":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T10:02:20Z","timestamp":1565863340000},"page":"134437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant \u03b1-synuclein mice"],"prefix":"10.1016","volume":"711","author":[{"given":"P.C.","family":"Keane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.G.","family":"Blain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hepplewhite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Khundakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8587-1731","authenticated-orcid":false,"given":"P.J.","family":"Kahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.E.N.","family":"LeBeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3749-0993","authenticated-orcid":false,"given":"C.M.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 5","key":"10.1016\/j.neulet.2019.134437_bib0005","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neulet.2019.134437_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2019.134437_bib0015","series-title":"Toxicological Profile for Trichloroethylene","first-page":"1","author":"Todd","year":"2019"},{"issue":"2","key":"10.1016\/j.neulet.2019.134437_bib0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.21288","article-title":"Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity","volume":"63","author":"Gash","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2019.134437_bib0025","article-title":"Solvent exposures and parkinson disease risk in twins","author":"Goldman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.neulet.2019.134437_bib0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1468-1331.1999.650609.x","article-title":"Trichloroethylene and parkinsonism: a human and experimental observation","volume":"6","author":"Guehl","year":"1999","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.neulet.2019.134437_bib0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0013-9351(03)00131-2","article-title":"Neurobehavioral effects of exposure to trichloroethylene through a municipal water supply","volume":"93","author":"Reif","year":"2003","journal-title":"Environ. Res."},{"issue":"3","key":"10.1016\/j.neulet.2019.134437_bib0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1471-4159.2009.06497.x","article-title":"Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats","volume":"112","author":"Liu","year":"2011","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.neulet.2019.134437_bib0045","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1007\/s12035-017-0830-x","article-title":"Trichloroethylene and Parkinson\u2019s disease: risk assessment","volume":"55","author":"Liu","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neulet.2019.134437_bib0050","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/abio.1999.4088","article-title":"Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2, 3,4-tetrahydro-beta-carboline in human blood after intake of the hypnotic chloral hydrate","volume":"270","author":"Bringmann","year":"1999","journal-title":"Anal. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.neulet.2019.134437_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)01308-0","article-title":"Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin?","volume":"442","author":"Riederer","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2019.134437_bib0060","first-page":"255","article-title":"Studies of the potentially endogenous toxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) in neuronal and glial cell cultures","volume":"46","author":"Rausch","year":"1995","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.neulet.2019.134437_bib0065","first-page":"275","article-title":"Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives","volume":"46","author":"Grote","year":"1995","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.neulet.2019.134437_bib0070","first-page":"283","article-title":"Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) after subchronic treatment in rats","volume":"46","author":"Sontag","year":"1995","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.neulet.2019.134437_bib0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-7091-6842-4_11","article-title":"The halogenated tetrahydro-beta-carboline \u201cTaClo\u201d: a progressively-acting neurotoxin","volume":"50","author":"Heim","year":"1997","journal-title":"J. Neural Transm. Suppl."},{"issue":"10","key":"10.1016\/j.neulet.2019.134437_bib0080","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00702-009-0261-6","article-title":"Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline","volume":"116","author":"Sontag","year":"2009","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"22","key":"10.1016\/j.neulet.2019.134437_bib0085","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP","volume":"99","author":"Dauer","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5321","key":"10.1016\/j.neulet.2019.134437_bib0090","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neulet.2019.134437_bib0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.neulet.2019.134437_bib0100","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1471-4159.2009.06165.x","article-title":"The Parkinson disease-associated A30P mutation stabilizes alpha-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells","volume":"110","author":"Song","year":"2009","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.neulet.2019.134437_bib0105","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","article-title":"Subcellular localization of wild-type and Parkinson\u2019s disease-associated mutant alpha -synuclein in human and transgenic mouse brain","volume":"20","author":"Kahle","year":"2000","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neulet.2019.134437_bib0110","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1046\/j.1471-4159.2001.00366.x","article-title":"Sensitivity to MPTP is not increased in Parkinson\u2019s disease-associated mutant alpha-synuclein transgenic mice","volume":"77","author":"Rathke-Hartlieb","year":"2001","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.neulet.2019.134437_bib0115","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0002-9440(10)63072-6","article-title":"Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model","volume":"159","author":"Kahle","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.neulet.2019.134437_bib0120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","article-title":"The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod","volume":"20","author":"Jones","year":"1968","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.neulet.2019.134437_bib0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0091-3057(78)90131-4","article-title":"A simple recording grip strength device","volume":"8","author":"Cabe","year":"1978","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neulet.2019.134437_bib0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.neulet.2019.134437_bib0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/h0077579","article-title":"Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat","volume":"93","author":"Barnes","year":"1979","journal-title":"J. Comp. Physiol. Psychol."},{"issue":"10","key":"10.1016\/j.neulet.2019.134437_bib0140","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1699-0463.1988.tb00954.x","article-title":"The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis","volume":"96","author":"Gundersen","year":"1988","journal-title":"APMIS"},{"issue":"4","key":"10.1016\/j.neulet.2019.134437_bib0145","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","article-title":"Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator","volume":"231","author":"West","year":"1991","journal-title":"Anat. Rec."},{"issue":"4","key":"10.1016\/j.neulet.2019.134437_bib0150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0892-0362(90)90061-G","article-title":"Effects of MPTP on locomotor activity in mice","volume":"12","author":"Colotla","year":"1990","journal-title":"Neurotoxicol. Teratol."},{"issue":"9","key":"10.1016\/j.neulet.2019.134437_bib0155","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.neurobiolaging.2006.06.013","article-title":"Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice","volume":"28","author":"Freichel","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.neulet.2019.134437_bib0160","doi-asserted-by":"crossref","first-page":"e00915","DOI":"10.1002\/brb3.915","article-title":"Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice","volume":"8","author":"Ekmark-Lewen","year":"2018","journal-title":"Brain Behav."},{"issue":"3","key":"10.1016\/j.neulet.2019.134437_bib0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1001958023096","article-title":"MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences","volume":"30","author":"Sedelis","year":"2000","journal-title":"Behav. Genet."},{"issue":"12","key":"10.1016\/j.neulet.2019.134437_bib0170","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/jnnp-2018-318337","article-title":"Developing and validating Parkinson\u2019s disease subtypes and their motor and cognitive progression","volume":"89","author":"Lawton","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2019.134437_bib0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-211-73574-9_18","article-title":"The long-term effects of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) on cognitive performance in rats","volume":"72","author":"Sontag","year":"2007","journal-title":"J. Neural. Transm. Suppl."},{"issue":"12","key":"10.1016\/j.neulet.2019.134437_bib0180","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/syn.20456","article-title":"Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression","volume":"61","author":"Fernagut","year":"2007","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.neulet.2019.134437_bib0185","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp. Neurol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019305403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019305403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:28:16Z","timestamp":1759609696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019305403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":37,"alternative-id":["S0304394019305403"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134437","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant \u03b1-synuclein mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"134437"}}